Hitoshi Kurumizaka graduated from the School of Pharmacy at Tokyo University of Pharmacy and Life Sciences in 1989. He joined the laboratory of Dr. Takehiko Shibata at RIKEN with the aim to study the mechanisms of DNA recombination. After receiving his Ph.D. in 1995, he started his post-doctoral training at the National Institutes of Health in the USA, in the laboratory of Dr. Alan Wolffe, where he broadened his scientific interest to the chromatin field. Two years later, he entered RIKEN as a research scientist. In 2003, he moved to Waseda University, first as an independent associate professor, then as a full professor in 2008. He has studied various nucleosomes and chromatin units by unraveling their structural and biochemical properties. In 2018, he moved to the Institute for Quantitative Biosciences, University of Tokyo, as a professor. His ongoing research interests are chromatin structure-based epigenetic regulatory mechanisms of genomic DNA in eukaryotes.
Hitoshi Kurumizaka graduated from the School of Pharmacy at Tokyo University of Pharmacy and Life Sciences in 1989. He joined the laboratory of Dr. Takehiko Shibata at RIKEN with the aim to study the mechanisms of DNA recombination. After receiving his Ph.D. in 1995, he started his post-doctoral training at the National Institutes of Health in the USA, in the laboratory of Dr. Alan Wolffe, where he broadened his scientific interest to the chromatin field. Two years later, he entered RIKEN as a research scientist. In 2003, he moved to Waseda University, first as an independent associate professor, then as a full professor in 2008. He has studied various nucleosomes and chromatin units by unraveling their structural and biochemical properties. In 2018, he moved to the Institute for Quantitative Biosciences, University of Tokyo, as a professor. His ongoing research interests are chromatin structure-based epigenetic regulatory mechanisms of genomic DNA in eukaryotes.